NASDAQ: AFJKAimei Health Technology Co Ltd Stock
$34.00+1.99 (+6.22%)
Updated Jun 17, 2026
AFJK Price
$34.00
Fair Value Price
-$0.50
Market Cap
$107.66M
52 Week Low
$6.75
52 Week High
$130.37
P/E
212.5x
P/B
-25.7x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$920.55k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1
Operating Cash Flow
-$416k
Beta
0.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AFJK Overview
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AFJK's potential to beat the market
- AFJK doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
AFJK
RankedUnranked of 30
RankedUnranked of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.81 | C | |
| $11.25 | C | |
| $12.39 | C |
Be the first to know about important AFJK news, forecast changes, insider trades & much more!
AFJK News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AFJK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AFJK ($34.00) is overvalued by 6,908.58% relative to our estimate of its Fair Value price of -$0.50 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
AFJK ($34.00) is not significantly undervalued (6,908.58%) relative to our estimate of its Fair Value price of -$0.50 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AFJK was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AFJK due diligence checks available for Premium users.
Valuation
AFJK fair value
Fair Value of AFJK stock based on Discounted Cash Flow (DCF)
Price
$34.00
Fair Value
-$0.50
Undervalued by
6,908.58%
AFJK ($34.00) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AFJK ($34.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AFJK was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AFJK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
212.5x
Industry
15.82x
Market
12.4x
AFJK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AFJK is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
AFJK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-25.7x
Industry
78.19x
AFJK's financial health
Profit margin
Revenue
$0.0
Net Income
$45.4k
Profit Margin
0%
AFJK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$12.3M
Liabilities
$4.2M
Debt to equity
-1
AFJK's short-term liabilities ($3.52M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AFJK's long-term liabilities ($690.00k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AFJK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AFJK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$74.6k
Investing
-$68.7k
Financing
$158.9k
AFJK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
AFJK vs Shell Company Stocks
Aimei Health Technology Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.